The Enterprise Value as of December 2024 (TTM) for Travere Therapeutics, Inc. (TVTX) is 1.84B

According to Travere Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.84B. This represents a change of 66.46% compared to the average of 1.11B of the last 4 quarters.

Travere Therapeutics, Inc. (TVTX) Historical Enterprise Value (quarterly & annually)

How has TVTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Travere Therapeutics, Inc. over the last ten years is 1.03B. The current 1.84B Enterprise Value has changed 17.70% with respect to the historical average. Over the past ten years (40 quarters), TVTX's Enterprise Value was at its highest in in the December 2021 quarter at 2.01B. The Enterprise Value was at its lowest in in the December 2014 quarter at 397.98M.

Travere Therapeutics, Inc. (TVTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Travere Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Travere Therapeutics, Inc. (TVTX) Average Enterprise Value

How has TVTX Enterprise Value performed in the past?

The current Enterprise Value of Travere Therapeutics, Inc. (TVTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Travere Therapeutics, Inc. (TVTX) Enterprise Value vs. Peers

How is TVTX’s Enterprise Value compared to its peers?

Travere Therapeutics, Inc.’s Enterprise Value is greater than DICE Therapeutics, Inc. (1.82B), less than Cytokinetics, Incorporated (6.45B), greater than Ventyx Biosciences, Inc. (109.78M), greater than Cogent Biosciences, Inc. (781.28M), less than Nuvalent, Inc. (5.51B), less than Cerevel Therapeutics Holdings, Inc. (8.24B), greater than Structure Therapeutics Inc. (1.45B), less than Revolution Medicines, Inc. (7.94B), greater than Akero Therapeutics, Inc. (1.71B), less than Avidity Biosciences, Inc. (3.35B), less than Protagonist Therapeutics, Inc. (2.20B), greater than Stoke Therapeutics, Inc. (448.16M), greater than IDEAYA Biosciences, Inc. (1.83B), greater than AnaptysBio, Inc. (251.68M), greater than MeiraGTx Holdings plc (443.72M), greater than Keros Therapeutics, Inc. (168.72M), greater than Homology Medicines, Inc. (-103303255.00), less than Legend Biotech Corporation (5.85B), less than Vaxcyte, Inc. (9.64B), less than Apellis Pharmaceuticals, Inc. (4.17B),

Build a custom stock screener for Travere Therapeutics, Inc. (TVTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Travere Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Travere Therapeutics, Inc. (TVTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Travere Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.